Fulton Bank’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.78M Sell
6,853
-411
-6% -$167K 0.1% 138
2025
Q1
$3.61M Sell
7,264
-897
-11% -$446K 0.15% 105
2024
Q4
$4.25M Buy
8,161
+288
+4% +$150K 0.16% 91
2024
Q3
$4.87M Sell
7,873
-241
-3% -$149K 0.19% 89
2024
Q2
$4.49M Buy
8,114
+479
+6% +$265K 0.18% 90
2024
Q1
$4.44M Sell
7,635
-61
-0.8% -$35.5K 0.18% 88
2023
Q4
$4.08M Buy
7,696
+208
+3% +$110K 0.18% 91
2023
Q3
$3.79M Sell
7,488
-73
-1% -$37K 0.19% 89
2023
Q2
$3.94M Sell
7,561
-225
-3% -$117K 0.19% 91
2023
Q1
$4.49M Buy
7,786
+20
+0.3% +$11.5K 0.24% 74
2022
Q4
$4.28M Buy
7,766
+391
+5% +$215K 0.24% 77
2022
Q3
$3.74M Buy
7,375
+432
+6% +$219K 0.22% 76
2022
Q2
$3.77M Buy
6,943
+166
+2% +$90.2K 0.21% 81
2022
Q1
$4M Buy
6,777
+799
+13% +$472K 0.19% 91
2021
Q4
$3.99M Buy
5,978
+208
+4% +$139K 0.18% 99
2021
Q3
$3.3M Buy
5,770
+1,213
+27% +$693K 0.15% 100
2021
Q2
$2.3M Buy
4,557
+146
+3% +$73.7K 0.11% 135
2021
Q1
$2.01M Sell
4,411
-132
-3% -$60.3K 0.1% 148
2020
Q4
$2.12M Buy
4,543
+162
+4% +$75.5K 0.11% 130
2020
Q3
$1.94M Sell
4,381
-632
-13% -$279K 0.12% 130
2020
Q2
$1.82M Sell
5,013
-112
-2% -$40.6K 0.12% 129
2020
Q1
$1.45M Buy
5,125
+371
+8% +$105K 0.12% 142
2019
Q4
$1.54M Buy
4,754
+203
+4% +$65.9K 0.1% 165
2019
Q3
$1.33M Buy
4,551
+128
+3% +$37.3K 0.09% 167
2019
Q2
$1.3M Buy
4,423
+110
+3% +$32.3K 0.09% 170
2019
Q1
$1.18M Buy
4,313
+128
+3% +$35K 0.08% 172
2018
Q4
$937K Buy
4,185
+145
+4% +$32.5K 0.07% 183
2018
Q3
$986K Buy
4,040
+414
+11% +$101K 0.06% 200
2018
Q2
$751K Buy
3,626
+152
+4% +$31.5K 0.05% 221
2018
Q1
$717K Buy
3,474
+1,061
+44% +$219K 0.05% 216
2017
Q4
$458K Buy
2,413
+209
+9% +$39.7K 0.03% 293
2017
Q3
$417K Buy
2,204
+234
+12% +$44.3K 0.03% 309
2017
Q2
$344K Buy
+1,970
New +$344K 0.03% 333